An ageing population, increased prevalence of chronic diseases, rising health insurance costs… the structural challenges facing our healthcare system are numerous. Against this backdrop, home healthcare service providers (HSPs) have become key players in the management of chronic diseases and the support of patients at home, against a backdrop of increasing demand for care and a lack of resources in healthcare establishments. However, they are currently experiencing a deterioration in their economic model, linked to the sector’s operating and regulatory framework and to inflation, which is having a major impact on their business.
Since April, the Nextep consultancy firm has been examining the future of the regulation of PSAD. The firm is analysing a service considered to be a “use case”, continuous positive airway pressure (CPAP) used in the treatment of sleep apnoea, a condition which, if inadequately managed, could cost up to €47 billion in France.The study sets out 11 recommendations for transforming the regulatory framework for the home healthcare sector and preserving high-quality care and access to innovation for patients treated at home in the years ahead. These recommendations are divided into three major, complementary areas:
ORIENTATION 1. Capitalise on new knowledge in the treatment of sleep apnoea to develop a more flexible management model that is better adapted to patients’ needs.
ORIENTATION 2. Reinforce medical cost control for the treatment of OSA in France
ORIENTATION 3. Improve the performance of the CPAP management framework
At a time when public authorities and the industry are calling for a concerted effort to define new regulatory procedures, Nextep’s firm hopes that this study will provide a basis that will enable all parties to identify ways in which the regulatory framework can evolve, with priority being given to the continuous improvement of patient care.
